← Back to headlines
FDA approves AstraZeneca’s new breast cancer medication
The U.S. Food and Drug Administration has granted regulatory approval for AstraZeneca’s latest treatment targeting breast cancer, expanding available therapeutic options for patients.
5 Sept, 01:15 — 5 Sept, 01:15
Sources
Showing 1 of 1 sources
